Senior Executives Highlight Mergers and Acquisitions and Expansions at DCAT Week ’18
At the DCAT Member Company Announcement Forum, held during DCAT Week, senior executives from member companies of the Drug, Chemical & Associated Technologies Association (DCAT) provided the latest major news from their companies impacting the pharmaceutical manufacturing value chain. So what did they report?
The executives highlighted key strategic activity, including mergers and acquisitions (M&A), post-M&A integration, and manufacturing expansions. Lonza, DowDuPont, Catalent, Novasep, CordenPharma, Piramal Pharma Solutions, SK biotek, Biocon, Procos, Nosco, AB BioTechnologies, and PolyCrystalLine were among the companies taking the podium to provide their latest developments.
The executives highlighted developments to expand active pharmaceutical ingredient (API) development and manufacturing (both small molecules and biologics), drug-product development and manufacturing (both solid dosage and parenteral drugs), and packaging. A roundup of these developments are provided in the stories below.
Lonza Updates Integration of $5.5-Billion Acquisition of Capsugel
DowDuPont Outlines Integration of Combined Company, Including Excipients Business
Catalent Updates Integration of $950-Million Acquisition of Cook Pharmica
Novasep Announces $65-Million Investment in Biologics
CordenPharma Outlines Integration of Former Pfizer API Facility
Piramal Pharma Solutions CEO Outlines Expansion Plans
SK biotek Outlines Integration of Former BMS API Manufacturing Facility
Biocon COO Highlights Company’s Growth Strategy
Procos CEO Outlines Expansion for High-Potency Manufacturing
Nosco President Discusses Company’s Growth Strategy in Wake of Two Key Acquisitions
AB BioTechnologies CEO Announces $12-Million Expansion
PolyCrystalLine CEO Announces Expansion of Solid-State Chemistry Capabilities
